Bis(2-hydroxy-3-tert-butyl-5-methyl-phenyl)-methane (bis-phenol) is a potent and selective inhibitor of the secretory pathway Ca2+ ATPase (SPCA1)

被引:10
|
作者
Lai, Pei [1 ]
Michelangeli, Francesco [1 ]
机构
[1] Univ Birmingham Edgbaston, Sch Biosci, Birmingham B15 2TT, W Midlands, England
基金
英国生物技术与生命科学研究理事会;
关键词
Ca2+ ATPase inhibitors; SPCA; SERCA; Calcium signalling; Golgi apparatus; SMOOTH-MUSCLE-CELLS; PUMP; HOMEOSTASIS; SENSITIVITY; EXPRESSION; MECHANISM; RECEPTOR; ATP2C1;
D O I
10.1016/j.bbrc.2012.07.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The secretory pathway Ca2+ ATPase (SPCA) provides the Golgi apparatus with a Ca2+ supply essential for Ca2+-dependent enzymes involved in the post-translational modification of proteins in transit through the secretory pathway. Ca2+ in the Golgi apparatus is also agonist-releasable and plays a role in hormone-induced Ca2+ transients. Although the Ca2+ ATPase inhibitors thapsigargin is more selective for the sarcoplasmic-endoplasmic reticulum Ca2+ ATPase (SERCA) than for SPCA, no inhibitor has been characterised that selectively inhibits SPCA. A number of inhibitors were assessed for their selectivity to the human SPCA1d compared to the more ubiquitous human SERCA2b. Each isoform was over-expressed in COS-7 cells and the Ca2+-dependent ATPase activity measured in their microsomal membranes. Both bis(2-hydroxy-3-tert-butyl-5-methylphenyl)methane(bis-phenol) and 2-aminoethoxydiphenylborate (2-APB) selectively inhibited SPCA1d (with IC50 values of 0.13 mu M and 0.18 mM, respectively), which were of 62- and 8.3-fold greater potency than the values for hSERCA2b (IC50 values; 8.1 mu M and 1.5 mM, respectively). Other inhibitors tested such as bis-phenol-A, tetrabromobisphenol-A and trifluoperazine inhibited both Ca2+ ATPases similarly. Furthermore, bis-phenol was able to mobilize Ca2+ in cells that had been pre-treated with thapsigargin. Therefore we conclude that given the potency and selectivity of bis-phenol it may prove a valuable tool in further understanding the role of SPCA in cellular processes. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:616 / 619
页数:4
相关论文
共 50 条
  • [31] Synthesis, thermal transformations, and mass spectrometric fragmentation of 4,4′-[1,2-bis(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)ethane-1,2-diyl]-bis(5-methyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one)
    Azev, Yu. A.
    Kovalev, I. S.
    Mekhaev, A. V.
    Gibor, A. M.
    Baranov, V. I.
    Bakulev, V. A.
    Ermakova, O. S.
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2013, 49 (04) : 545 - 550
  • [32] Synthesis, thermal transformations, and mass spectrometric fragmentation of 4,4'-[1,2-bis(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)ethane-1,2-diyl]-bis(5-methyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one)
    Yu. A. Azev
    I. S. Kovalev
    A. V. Mekhaev
    A. M. Gibor
    V. I. Baranov
    V. A. Bakulev
    O. S. Ermakova
    Chemistry of Heterocyclic Compounds, 2013, 49 : 545 - 550
  • [33] A highly stable and luminescent mononuclear Cu(I) bis-{5-tert-butyl-3-(6-methyl-2-pyridyl)-1H-1,2,4-triazole} complex
    Luo, Yan-Sheng
    Chen, Jing-Lin
    Zeng, Xue-Hua
    Qiu, Lu
    He, Li-Hua
    Liu, Sui-Jun
    Wen, He-Rui
    CHINESE CHEMICAL LETTERS, 2017, 28 (05) : 1027 - 1030
  • [34] Synthesis, structure, and properties of a binuclear Fe(III) complex with N-(1-propanol)-N,N-bis(3-tert-butyl-5-methyl-2-hydroxybenxyl)amine
    Xing-wu Tan
    Jin-ye Chen
    Xiao-hua Xie
    Shu-zhong Zhan
    Yuan-fu Deng
    Transition Metal Chemistry, 2010, 35 : 999 - 1003
  • [35] Synthesis, structure, and properties of a binuclear Fe(III) complex with N-(1-propanol)-N,N-bis(3-tert-butyl-5-methyl-2-hydroxybenxyl)amine
    Tan, Xing-wu
    Chen, Jin-ye
    Xie, Xiao-hua
    Zhan, Shu-zhong
    Deng, Yuan-fu
    TRANSITION METAL CHEMISTRY, 2010, 35 (08) : 999 - 1003
  • [36] ABT-963 [2-(3,4-Difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor
    Harris, RR
    Black, L
    Surapaneni, S
    Kolasa, T
    Majest, S
    Namovic, MT
    Grayson, G
    Komater, V
    Wilcox, D
    King, L
    Marsh, K
    Jarvis, MF
    Nuss, M
    Nellans, H
    Pruesser, L
    Reinhart, GA
    Cox, B
    Jacobson, P
    Stewart, A
    Coghlan, M
    Carter, G
    Bell, RL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (03): : 904 - 912
  • [37] 1-[3-(2-Benzyloxy-6-hydroxy-4-methyl-phenyl)-5-[3,5-bis(trifluoromethyl)-phenyl]-4,5-dihydro-1H-pyrazol-1-yl]propane-1-one
    Patel, U. H.
    Gandhi, S. A.
    Barot, V. M.
    Varma, N. V. S.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O840 - +
  • [38] Potent Activation of Large-Conductance Ca2+-Activated K+ Channels by the Diphenylurea 1,3-Bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in Pituitary Tumor (GH3) Cells
    Wu, Sheng-Nan
    Peng, Hsung
    Chen, Bing-Shuo
    Wang, Ya-Jean
    Wu, Pei-Yu
    Lin, Ming-Wei
    MOLECULAR PHARMACOLOGY, 2008, 74 (06) : 1696 - 1704
  • [39] Synthesis and Crystal Structure Analysis of 3,3'-[(3-Sulfanyl Phenyl)Methylene]Bis(4-Hydroxy-2H-1-Benzopyran-2-One): 5-Methyl-1,3-Thiazol-2(3H)-Imine
    Sharma, G.
    Anthal, S.
    Deshmukh, M. B.
    Mohire, P. P.
    Bhosale, T. R.
    Sudarsanakumar, C.
    Kant, R.
    CRYSTALLOGRAPHY REPORTS, 2021, 66 (07) : 1233 - 1237
  • [40] Synthesis and Crystal Structure Analysis of 3,3'-[(3-Sulfanyl Phenyl)Methylene]Bis(4-Hydroxy-2H-1-Benzopyran-2-One) : 5-Methyl-1,3-Thiazol-2(3H)-Imine
    G. Sharma
    S. Anthal
    M. B. Deshmukh
    P. P. Mohire
    T. R. Bhosale
    C. Sudarsanakumar
    R. Kant
    Crystallography Reports, 2021, 66 : 1233 - 1237